TARDBP and amyotrophic lateral sclerosis: Despite differences in the transgenic mouse model and inhibitor used, the study testing IGS-2.7 in TDP-43 (A315T) mice concluded that inhibitor treatment preserved spinal cord motor neurons and reduced glial immunoreactivity [34], which aligns with our findings on the disease-promoting role of TDP-43 phosphorylation in ALS.